Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation

Digestive Diseases and Sciences

Volumn 43, Issue 6, 1998, Pages 1186-1189

  Herrero, J Ignacio ^a   Quiroga, Jorge ^a   Sangro, Bruno ^a   Sola, Iosu ^a   Riezu Boj, Jose Ignacio ^a   Pardo, Fernando ^a   Prieto, Jesus ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Hepatitis B; Lamivudine; Liver transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; CYCLOSPORIN; FAMCICLOVIR; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PREDNISONE; VIRUS DNA;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENT INFECTION;

ACUTE DISEASE; BILIRUBIN; DNA, VIRAL; HEPATITIS B; HUMANS; LAMIVUDINE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RECURRENCE; REVERSE TRANSCRIPTASE INHIBITORS; TRANSAMINASES;

EID: 0031744662     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018887203545     Document Type: Article

References (16)

1. Wright TL: Liver transplantation in patients with chronic hepatitis B and hepatitis C. In Transplantation of the Liver, 2nd ed. WC Maddrey, MF Sorrell (eds.). Norwalk, Appleton & Lange, 1995, pp 477-501
2. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H: Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 329:1842-1847, 1993
3. Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC, Lindsay K, Payne J, Dienstag JL, O'Brien C, Tamburro C, Jacobson MI, Sampliner R, Feit D, Lefkowitch J, Kuhns M, Meschievitz C, Sanghvi B, Albrecht J, Gibas A, Hepatitis Interventional Therapy Group: A randomized, controlled trial of interferon alfa-2b alone after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 323:295-301, 1990
4. Terrault NA, Combs Holland C, Ferrell L, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL: Interferon alfa for recurrent hepatitis B infection after liver transplantation. Liver Transplant Surg 2:132-138, 1996
5. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M: A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 333:1657-1661, 1995
6. Lai CL, Liaw YF, Leung NWY, Chang TT, Guan R, Tai DI, Ng KY, Wu PC, Dent JC, Gray DF: 12 months of lamivudine (100 mg od) therapy improves liver histology: Results of a placebo controlled multicentre study in Asia. J Hepatol 26(suppl 1):79, 1997
7. Benhamou Y, Dohin E, Luniel-Fabiani F, Poynard T, Huraux JM, Katlama C, et al: Efficacy of lamivudine in replication of hepatitis B virus in HIV-infected patients. Lancet 345:396-397, 1995
8. Grellier L, Mutimer D, Ahmed M, Brown D, Burroughs AK, Rolles K, McMaster P, Beranek P, Kennedy F, Kibbler H, McPhillips P, Elias E, Dusheiko G: Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 348:1212-1215, 1996
9. McKenzie R, Fried MW, Sallie R, Conjeevaram H, Di Bisceglie AM, Park Y, Savarese B, Kleiner D, Tsokos M, Luciano C, Pruett T, Stotka JL, Straus SE, Hoofnagle JH: Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for hepatitis B. N Engl J Med 333:1099-1105, 1995
10. Samuel D, Bismuth A, Mathieu D, Arulnaden J, Raynes M, Benhamou J, Brechot C, et al: Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet 337:813-815, 1991
11. Lau JYN, Davies SE, Bain VG, O'Grady JG, Alberti A, Alexander GJM, Williams R: High level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology 102:956-962, 1992
12. Marcellin P, Samuel D, Loriot MA, Areias J, Bismuth H, Benhamou JP: Antiviral effect of adenine arabinoside monophosphate (ARA-AMP) in patients with recurrence of hepatitis B virus (HBV) infection after liver transplantation. Hepatology 12:966A, 1990
13. Lok ASF, Wilson LA, Thomas HC: Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection. J Antimicrob Chemother 14:93-99, 1984
14. Gish RG, Lau JYN, Brooks L, Fang JWS, Steady SL, Imperial JC, Garcia-Kennedy R, et al: Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 23:1-7, 1996
15. Rabinovitz M, Dodson F, Rakela J: Famciclovir for recurrent hepatitis B (HBV) infection after liver transplantation (OLTX). Hepatology 24:282A, 1996
16. Perrillo R, Rakela J, Martin P, Levy G, Schiff E, Wright T, Dienstag J, Gish R, Villeneuve J, Caldwell S, Brown N, Self P, Lamivudine Transplant Study Group: Lamivudine for hepatitis B after liver transplantation (OLT). Hepatology 24:182A, 1996